Biosimilars Education


Amgen is committed to being a reliable resource on biosimilars for prescribers and patients. By focusing on education, we hope to foster a higher understanding on the potential value biosimilars can bring to the healthcare system.

Everything You Need To Know About Biosimilars

About Biosimilars

Biosimilars are biologic medicines that are highly similar to existing approved biological products, with no clinically significant differences in safety and efficacy.

Suggested Readings

The Values & Benefits of Biosimilars  Biologics vs. Generics 

Prescribing Biosimilars

Patients and their healthcare providers can expect that there will be no clinically meaningful differences between taking a reference product and a biosimilar when these products are used as intended. The decision to prescribe a biosimilar should be made by a healthcare provider in consultation with the patient or caregiver.

Suggested Readings

Biosimilars Safety & Efficacy  Discussing Biosimilars with Patients 

Biosimilars Development and Regulatory Pathways

Rigorous regulatory approval pathways require the biosimilar manufacturer to demonstrate similarity with no clinically meaningful differences to the reference product through an intricate step-wise process.

Suggested Readings

Complexities of Biosimilars Development  Regulatory Approval Pathways 

Practical Help

Find definitions and more information at the links below.